InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by MELTZER LESLIE, Chief Research and Development. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been logged. Regulator: SEC (Form 4). All data is free.
Declarations2 total
107,024 shares
Common Stock
SEC:0001193125-26-224620·
107,024 shares
Common Stock
SEC:0001193125-26-224620:0·
2 of 2 declarations
About MELTZER LESLIE
Leslie Meltzer is the Chief Research and Development Officer at Apellis Pharmaceuticals, Inc. In this role, she oversees the company's research and development initiatives, focusing on innovative therapies to treat serious diseases. Ms. Meltzer plays a key role in guiding research projects and collaborating with scientific teams to ensure the success of product developments.
